Cargando…

Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK–ERK Pathway

SIMPLE SUMMARY: Higher neutrophil-derived cytokine lipocalin-2 (LCN2) expression possesses a versatile role in a myriad of cancers, but little is known about the role of LCN2 on osteosarcoma metastasis. In this study, we demonstrated that higher LCN2 inhibited cellular motility, migration, and invas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Ko-Hsiu, Yang, Jia-Sin, Hsieh, Yi-Hsien, Chu, Hsiao-Ju, Chou, Chia-Hsuan, Lu, Eric Wun-Hao, Lin, Chiao-Wen, Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268143/ https://www.ncbi.nlm.nih.gov/pubmed/34202288 http://dx.doi.org/10.3390/cancers13133181

Ejemplares similares

Lipocalin 2 Reduces MET Levels by Inhibiting MEK/ERK Signaling to Inhibit Nasopharyngeal Carcinoma Cell Migration
por: Li, Ju-Pi, et al.
Publicado: (2022)

Tomatidine Represses Invasion and Migration of Human Osteosarcoma U2OS and HOS Cells by Suppression of Presenilin 1 and c-Raf–MEK–ERK Pathway
por: Hsieh, Min-Hong, et al.
Publicado: (2020)

HO-3867 Induces Apoptosis via the JNK Signaling Pathway in Human Osteosarcoma Cells
por: Lu, Peace Wun-Ang, et al.
Publicado: (2022)

Apoptotic effect and cell arrest of deoxyshikonin in human osteosarcoma cells through the p38 pathway
por: Hsieh, Ming‐Chang, et al.
Publicado: (2023)

Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway
por: Yeh, Liang-Tsai, et al.
Publicado: (2022)

Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression
por: Cheng, Hsin-Lin, et al.
Publicado: (2016)

GO-Y078, a Curcumin Analog, Induces Both Apoptotic Pathways in Human Osteosarcoma Cells via Activation of JNK and p38 Signaling
por: Lu, Peace Wun-Ang, et al.
Publicado: (2021)

Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2023)

Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2019)

Zoledronate blocks geranylgeranylation not farnesylation to suppress human osteosarcoma U2OS cells metastasis by EMT via Rho A activation and FAK-inhibited JNK and p38 pathways
por: Cheng, Hsin-Lin, et al.
Publicado: (2016)

Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9
por: Hsieh, Min-Hong, et al.
Publicado: (2019)

CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells
por: Yang, Jia-Sin, et al.
Publicado: (2019)

Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells’ Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway
por: Lu, Ko-Hsiu, et al.
Publicado: (2020)

Licochalcone A-Induced Apoptosis Through the Activation of p38MAPK Pathway Mediated Mitochondrial Pathways of Apoptosis in Human Osteosarcoma Cells In Vitro and In Vivo
por: Lin, Renn-Chia, et al.
Publicado: (2019)

Potential Antimetastatic Effect of Timosaponin AIII against Human Osteosarcoma Cells through Regulating the Integrin/FAK/Cofilin Axis
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

Hematopoietic cell kinase enhances osteosarcoma development via the MEK/ERK pathway
por: Liu, Weibo, et al.
Publicado: (2021)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

A c-Met Inhibitor Suppresses Osteosarcoma Progression via the ERK1/2 Pathway in Human Osteosarcoma Cells
por: Chen, Weijie, et al.
Publicado: (2021)

Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer
por: Chung, I-Hsiao, et al.
Publicado: (2015)

MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis
por: Lin, Chia-Liang, et al.
Publicado: (2021)

Association of RDM1 with osteosarcoma progression via cell cycle and MEK/ERK signalling pathway regulation
por: Sheng, Jun, et al.
Publicado: (2021)

Urinary Neutrophil Gelatinase-Associated Lipocalin Is a Potential Biomarker for Renal Damage in Patients with Systemic Lupus Erythematosus
por: Yang, Chun-Chen, et al.
Publicado: (2012)

TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling
por: Xia, Kezhou, et al.
Publicado: (2023)

DHFR and MDR1 upregulation is associated with chemoresistance in osteosarcoma stem-like cells
por: Lee, Yu-Hsien, et al.
Publicado: (2017)

Morusin Suppresses Cancer Cell Invasion and MMP-2 Expression through ERK Signaling in Human Nasopharyngeal Carcinoma
por: Huang, Cheng-Chen, et al.
Publicado: (2020)

Andrographolide suppresses the migratory ability of human glioblastoma multiforme cells by targeting ERK1/2-mediated matrix metalloproteinase-2 expression
por: Yang, Shih-Liang, et al.
Publicado: (2017)

Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway
por: Wei, Zhun, et al.
Publicado: (2023)

Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells
por: Yang, Jia-Sin, et al.
Publicado: (2017)

Overexpression of Lipocalin-2 Inhibits Proliferation and Invasiveness of Human Glioblastoma Multiforme Cells by Activating ERK Targeting Cathepsin D Expression
por: Hsieh, Yi-Hsien, et al.
Publicado: (2021)

MEK/ERK addiction in CNL/aCML
por: Kesarwani, Meenu, et al.
Publicado: (2017)

Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines
por: Hsin, Min-Chieh, et al.
Publicado: (2022)

PRIMA-1(Met) suppresses colorectal cancer independent of p53 by targeting MEK
por: Lu, Tao, et al.
Publicado: (2016)

Lipocalin-2-induced cytokine production enhances endometrial carcinoma cell survival and migration
por: Lin, Hsiu-Hsia, et al.
Publicado: (2011)

Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan
por: Chou, Chia-Hsuan, et al.
Publicado: (2017)

Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas
por: Yang, Shun-Fa, et al.
Publicado: (2014)

Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma
por: Yeh, Chao-Bin, et al.
Publicado: (2014)

Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer
por: Qian, Liqiang, et al.
Publicado: (2020)

Mitophagy Effects of Protodioscin on Human Osteosarcoma Cells by Inhibition of p38MAPK Targeting NIX/LC3 Axis
por: Huang, Chien-Feng, et al.
Publicado: (2023)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020)

The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
por: Thomas, Kubin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4j49sjm3tkedcqlp45kdrq6cl2